6o3d: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal structure of the unbound Fab fragment of the human HIV-1 neutralizing antibody PGZL1.== | |||
<StructureSection load='6o3d' size='340' side='right'caption='[[6o3d]], [[Resolution|resolution]] 1.40Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6o3d]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O3D OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6O3D FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |||
[[Category: | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6o3g|6o3g]], [[6o3j|6o3j]], [[6o3k|6o3k]], [[6o3l|6o3l]], [[6o3u|6o3u]], [[6o41|6o41]], [[6o42|6o42]]</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6o3d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o3d OCA], [http://pdbe.org/6o3d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6o3d RCSB], [http://www.ebi.ac.uk/pdbsum/6o3d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6o3d ProSAT]</span></td></tr> | |||
</table> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Irimia, A]] | |||
[[Category: Wilson, I A]] | |||
[[Category: Broadly neutralising hiv-1 antibody]] | |||
[[Category: Gp41 mper]] | |||
[[Category: Immune system]] | |||
[[Category: Membrane lipid]] | |||
[[Category: Pgzl1 anti hiv-1]] | |||
Revision as of 08:11, 4 December 2019
Crystal structure of the unbound Fab fragment of the human HIV-1 neutralizing antibody PGZL1.
| ||||||||||||
